BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 27441654)

  • 1. Tankyrase inhibition aggravates kidney injury in the absence of CD2AP.
    Kuusela S; Wang H; Wasik AA; Suleiman H; Lehtonen S
    Cell Death Dis; 2016 Jul; 7(7):e2302. PubMed ID: 27441654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tankyrase Regulates Neurite Outgrowth through Poly(ADP-ribosyl)ation-Dependent Activation of β-Catenin Signaling.
    Mashimo M; Kita M; Uno A; Nii M; Ishihara M; Honda T; Gotoh-Kinoshita Y; Nomura A; Nakamura H; Murayama T; Kizu R; Fujii T
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L; Wang X; Jia T; Wei W; Chua MS; So S
    Oncotarget; 2015 Sep; 6(28):25390-401. PubMed ID: 26246473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Poly(ADP-ribose) Polymerase Enzyme Tankyrase Antagonizes Activity of the β-Catenin Destruction Complex through ADP-ribosylation of Axin and APC2.
    Croy HE; Fuller CN; Giannotti J; Robinson P; Foley AVA; Yamulla RJ; Cosgriff S; Greaves BD; von Kleeck RA; An HH; Powers CM; Tran JK; Tocker AM; Jacob KD; Davis BK; Roberts DM
    J Biol Chem; 2016 Jun; 291(24):12747-12760. PubMed ID: 27068743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tankyrase is necessary for canonical Wnt signaling during kidney development.
    Karner CM; Merkel CE; Dodge M; Ma Z; Lu J; Chen C; Lum L; Carroll TJ
    Dev Dyn; 2010 Jul; 239(7):2014-23. PubMed ID: 20549720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survival.
    Yaddanapudi S; Altintas MM; Kistler AD; Fernandez I; Möller CC; Wei C; Peev V; Flesche JB; Forst AL; Li J; Patrakka J; Xiao Z; Grahammer F; Schiffer M; Lohmüller T; Reinheckel T; Gu C; Huber TB; Ju W; Bitzer M; Rastaldi MP; Ruiz P; Tryggvason K; Shaw AS; Faul C; Sever S; Reiser J
    J Clin Invest; 2011 Oct; 121(10):3965-80. PubMed ID: 21911934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tankyrase-mediated β-catenin activity regulates vasopressin-induced AQP2 expression in kidney collecting duct mpkCCDc14 cells.
    Jung HJ; Kim SY; Choi HJ; Park EJ; Lim JS; Frøkiaer J; Nielsen S; Kwon TH
    Am J Physiol Renal Physiol; 2015 Mar; 308(5):F473-86. PubMed ID: 25520007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase.
    Koirala S; Klein J; Zheng Y; Glenn NO; Eisemann T; Fon Tacer K; Miller DJ; Kulak O; Lu M; Finkelstein DB; Neale G; Tillman H; Vogel P; Strand DW; Lum L; Brautigam CA; Pascal JM; Clements WK; Potts PR
    Cell Rep; 2020 Jul; 32(3):107922. PubMed ID: 32698014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl)ation and scaffolding.
    Mariotti L; Pollock K; Guettler S
    Br J Pharmacol; 2017 Dec; 174(24):4611-4636. PubMed ID: 28910490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARsing the phrase "all in for Axin"- Wnt pathway targets in cancer.
    Fearon ER
    Cancer Cell; 2009 Nov; 16(5):366-8. PubMed ID: 19878868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic conditions downregulate the expression of CD2AP in podocytes via PI3-K/Akt signalling.
    Ha TS; Hong EJ; Han GD
    Diabetes Metab Res Rev; 2015 Jan; 31(1):50-60. PubMed ID: 24846128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of SHIP2 in CD2AP-deficient podocytes ameliorates reactive oxygen species generation but aggravates apoptosis.
    Saurus P; Tolvanen TA; Lindfors S; Kuusela S; Holthöfer H; Lehtonen E; Lehtonen S
    Sci Rep; 2017 Sep; 7(1):10731. PubMed ID: 28878342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tankyrases induces Axin stabilization and blocks Wnt signalling in breast cancer cells.
    Bao R; Christova T; Song S; Angers S; Yan X; Attisano L
    PLoS One; 2012; 7(11):e48670. PubMed ID: 23144924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD2-associated protein/phosphoinositide 3-kinase signaling has a preventive role in angiotensin II-induced podocyte apoptosis.
    Park HY; Seong SB; Min SY; Ha TS
    Int J Biochem Cell Biol; 2016 Oct; 79():370-381. PubMed ID: 27590856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CD2-associated protein in albumin overload-induced apoptosis in podocytes.
    He FF; Zhang C; Chen S; Deng BQ; Wang H; Shao N; Tian XJ; Fang Z; Sun XF; Liu JS; Zhu ZH; Meng XF
    Cell Biol Int; 2011 Aug; 35(8):827-34. PubMed ID: 21166652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte Wnt/ß-catenin pathway is activated by integrin-linked kinase in clinical and experimental focal segmental glomerulosclerosis.
    Naves MA; Requião-Moura LR; Soares MF; Silva-Júnior JA; Mastroianni-Kirsztajn G; Teixeira VP
    J Nephrol; 2012; 25(3):401-9. PubMed ID: 21928230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fractalkine is Involved in Lipopolysaccharide-Induced Podocyte Injury through the Wnt/β-Catenin Pathway in an Acute Kidney Injury Mouse Model.
    Senouthai S; Wang J; Fu D; You Y
    Inflammation; 2019 Aug; 42(4):1287-1300. PubMed ID: 30919150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling.
    Huang SM; Mishina YM; Liu S; Cheung A; Stegmeier F; Michaud GA; Charlat O; Wiellette E; Zhang Y; Wiessner S; Hild M; Shi X; Wilson CJ; Mickanin C; Myer V; Fazal A; Tomlinson R; Serluca F; Shao W; Cheng H; Shultz M; Rau C; Schirle M; Schlegl J; Ghidelli S; Fawell S; Lu C; Curtis D; Kirschner MW; Lengauer C; Finan PM; Tallarico JA; Bouwmeester T; Porter JA; Bauer A; Cong F
    Nature; 2009 Oct; 461(7264):614-20. PubMed ID: 19759537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway.
    Wu X; Luo F; Li J; Zhong X; Liu K
    Int J Oncol; 2016 Apr; 48(4):1333-40. PubMed ID: 26820603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.